Clinical Trial Update: Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) [Phase 2]

View source ↗

Summary

Phase II clinical trial of topical artesunate ointment for vulvar high-grade intraepithelial neoplasia (VIN2/3) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Vulvar High-grade Intraepithelial Neoplasia
• Vulvar Intraepithelial Neoplasia

Drugs mentioned

• Artesunate ointment (Artesunate)

Snippet

Sponsor: Frantz Viral Therapeutics, LLC | Conditions: Vulvar Diseases, HPV Infection | Phase 2 | Status: RECRUITING